CWA Asset Management Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Sell
638
-6,718
-91% -$3.77M 0.01% 565
2026
Q1
$4.13M Buy
7,356
+6,847
+1,345% +$4.39M 0.14% 151
2025
Q4
$344K Buy
509
+17
+3% +$11.6K 0.01% 520
2025
Q3
$314K Buy
492
+31
+7% +$18.8K 0.01% 552
2025
Q2
$247K Buy
+461
New +$220K 0.01% 577
2024
Q4
Sell
-609
Closed -$308K 592
2024
Q3
$308K Buy
+609
New +$296K 0.02% 470

Other funds holding IDXX

CWA Asset Management Group's IDXX Position: Q2 2026 in Review

CWA Asset Management Group reduced its Idexx Laboratories (IDXX) stake by 91% in Q2 2026, selling an estimated $3.77M and leaving 638 shares worth $336K. The position accounts for 0.01% of the portfolio, ranked #565.

CWA Asset Management Group first reported a position in IDXX in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.13M in Q1 2026. 612 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • CWA Asset Management Group held 638 shares of Idexx Laboratories worth $336K as of Q2 2026.
  • CWA Asset Management Group sold 6,718 Idexx Laboratories shares in Q2 2026, an estimated $3.77M.
  • Idexx Laboratories made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #565 holding.
  • CWA Asset Management Group first reported a position in Idexx Laboratories in Q3 2024 and has held it in 6 quarters since.
  • CWA Asset Management Group's Idexx Laboratories position peaked at $4.13M in Q1 2026.
  • 612 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.